Página 7 - Mayores valores de U.S. Pharmaceuticals & Biotech por capitalización bursátil

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

ACTUALIZADO May 26, 2026

Descubra las empresas de gran capitalización U.S. Pharmaceuticals & Biotech que cotizan en NYSE y NASDAQ. Estas Pharmaceuticals & Biotech Companies están organizadas por capitalización bursátil.

710 empresas

Empresa	Último precio	7D Retorno	Rendimiento 1 año	Capitalización bursátil	Objetivo de los analistas	Valoración	Crecimiento	Div Rendimiento
SION	US$42.88	13.8%	227.8%	US$1.9b	US$51.60	6.7	-12.5%	n/a
IOVA	US$4.10	18.5%	137.0%	US$1.8b	US$8.80	6.4	67.1%	n/a
STOK	US$31.03	3.6%	238.0%	US$1.8b	US$45.10	60.2	44.7%	n/a
NRIX	US$17.38	14.0%	77.9%	US$1.8b	US$30.18	25.0	16.2%	n/a
RAPP	US$39.71	15.5%	295.5%	US$1.8b	US$57.10	95.0	-16.1%	n/a
OCUL	US$8.29	3.8%	19.5%	US$1.8b	US$26.00	34.9	38.7%	n/a
SRPT	US$16.67	0.2%	-56.5%	US$1.8b	US$22.00	27.1	-41.8%	n/a
VCEL	US$34.97	1.4%	-16.9%	US$1.8b	US$55.43	83.2	33.6%	n/a
SNDX	US$19.90	2.8%	100.4%	US$1.8b	US$39.25	8.1	68.7%	n/a
NTLA	US$12.61	5.6%	35.2%	US$1.8b	US$26.63	26.7	65.7%	n/a
ANIP	US$81.41	1.4%	39.6%	US$1.8b	US$109.88	20.6	30.4%	n/a
HRMY	US$30.09	-1.1%	-11.0%	US$1.7b	US$44.36	12.0	18.2%	n/a
OCS	US$29.93	7.0%	50.5%	US$1.7b	US$51.79	1239.2	42.3%	n/a
ANAB	US$57.77	-3.3%	187.0%	US$1.7b	US$84.45	7.2	47.0%	39.0%
AGIO	US$28.33	2.2%	-6.2%	US$1.7b	US$41.13	25.5	38.2%	n/a
CAPR	US$29.36	9.1%	180.2%	US$1.7b	US$54.11	6.1	64.6%	n/a
INVA	US$22.68	4.4%	18.4%	US$1.7b	US$35.50	3.3	-22.6%	0%
NUVB	US$4.69	10.6%	109.4%	US$1.6b	US$12.33	11.4	63.6%	n/a
PVLA	US$117.59	7.7%	412.6%	US$1.6b	US$229.00	7.3	59.9%	n/a
CMPS	US$12.23	21.4%	185.6%	US$1.6b	US$22.20	5.0	55.6%	n/a
GLUE	US$19.20	9.2%	381.2%	US$1.6b	US$32.33	37.8	-10.5%	n/a
ABCL	US$5.29	30.6%	167.2%	US$1.6b	US$10.43	20.4	-11.0%	n/a
ATAI	US$4.29	8.3%	94.1%	US$1.6b	US$14.00	451.3	51.3%	n/a
GHRS	US$23.15	2.7%	84.2%	US$1.6b	US$39.50	6.0	3.9%	n/a

Page 7 of 30